Title:
ANTIVIRAL COMPOSITION CONTAINING GINSENG EXTRACT AND STEROID COMPOUND AS ACTIVE INGREDIENTS
Document Type and Number:
WIPO Patent Application WO/2024/058427
Kind Code:
A1
Abstract:
A composition containing a steroid compound and a ginseng extract selected from the group consisting of a ginseng extract, a red ginseng extract, and a black ginseng extract as active ingredients provided by the present invention has a wide range of inhibitory activity against viruses, and therefore is useful for effectively preventing, ameliorating, or treating infections caused by viruses or diseases caused by infections.
Inventors:
AN JUNMIN (KR)
Application Number:
PCT/KR2023/011426
Publication Date:
March 21, 2024
Filing Date:
August 03, 2023
Export Citation:
Assignee:
GINSENG BYPHARM CO LTD (KR)
International Classes:
A61K36/258; A23K10/12; A23K10/30; A23K20/168; A23L33/10; A23L33/105; A61K31/573; A61K31/58; A61K45/06; A61P31/12
Domestic Patent References:
| WO2021164723A1 | 2021-08-26 |
Foreign References:
| KR20220109577A | 2022-08-05 | |||
| KR20220115677A | 2022-08-18 | |||
| KR20220059157A | 2022-05-10 |
Other References:
ZHANG YONGJING; HU SHILING; WANG JUE; XUE ZHUOYIN; WANG CHENG; WANG NAN: "Dexamethasone inhibits SARS-CoV-2 spike pseudotyped virus viropexis by binding to ACE2", VIROLOGY, ELSEVIER, AMSTERDAM, NL, vol. 554, 16 December 2020 (2020-12-16), AMSTERDAM, NL , pages 83 - 88, XP086447498, ISSN: 0042-6822, DOI: 10.1016/j.virol.2020.12.001
Attorney, Agent or Firm:
LEE, Sang-moon et al. (KR)
Download PDF: